Synopsis
To review the basic physical and algorithmic concepts of quantitative susceptibility mapping and to discuss technical issues and more recent developments.Highlights
- Magnetic
susceptibility differences between tissues produce spatial variation in MRI resonance
frequency
(and thus phase) that can be utilized in gradient-echo based sequences
for creating tissue contrast
- A
non-local relationship exists between measured phase variation and underlying
susceptibility distribution
- Creating
susceptibility maps from phase data is challenging due to the ill-posed nature
of the required field-
to-source inversion
- Anisotropic
susceptibility can be evaluated by susceptibility tensor imaging which allows assessment
of
tissue microstructure and fiber orientation
- QSM and STI provide a novel quantitative contrast of
an intrinsic physical tissue quantity
TARGET AUDIENCE
MR researchers and clinicians interested in understanding the principles of quantitative magnetic susceptibility mapping SUMMARY
Magnetic susceptibility describes the magnetizability of
a material in response to an applied magnetic field and represents an important physical
quantity in the field of MRI. Since the earliest days of MRI, quantification of
magnetic susceptibility was considered an important goal as it was anticipated
that magnetic susceptibility, similar to T1 and T2
relaxation constants, could be useful to characterize diseased tissue. With the
recently introduced method of quantitative susceptibility mapping (QSM) and its
conceptual extension to susceptibility tensor imaging (STI), non-invasive and
spatially resolved assessment of this physical quantity has become possible by
solving the ill-posed inverse problem to determine magnetic susceptibility from
local magnetic fields.
Gradient-echo (GRE) sequences are particularly suited
in this respect, since their associated phase maps or, equivalently frequency
maps, are reflecting the sample’s magnetization and thus its magnetic
susceptibility. QSM is made possible by, first, estimating the magnetic field
distribution from raw MRI phase data of tissue whose contrast is based on
off-resonance phase accumulation during TE so that phase in the final image is
largely determined by timing of acquisition at the center of k-space, second, eliminating background
field contributions that result from susceptibility sources outside of the area
of interest (e.g., brain) and, third, solving the inverse problem from field
perturbation to magnetic susceptibility by applying deconvolution with a
magnetic dipole field kernel. The latter process implicitly assumes that the
magnetic field distribution can be considered as the superposition of dipole
fields generated by each voxel whereupon each voxel is represented by a
particular value of magnetic susceptibility.
All these steps hinted at above need careful consideration when setting up the imaging and reconstruction pipeline. Demarcation of regions with internal magnetic field variations essential for background field removal as well as identification of unreliable phase values are important details that need special consideration. Several methods to overcome the ill-posed nature of
the inversion problem have been developed, which rely either on repeated
measurements of the object after having been rotated with respect to the
magnetic field and combining data or in case of single orientation imaging on
the utilization of non-iterative k-space
(e.g., simple k-space thresholding)
or iterative image-space based regularization methods. With regularization one seeks
to incorporate a priori knowledge into
the solution process (i.e. knowledge like, e.g., amount or type of noise, smoothness
or sparsity of the solution, or restrictions on the values the solution may
take on), which also requires choosing one or more regularization parameters.
One major demand on any inversion algorithm is its ability to reconstruct subtle tissue susceptibility variations while simultaneously suppressing artifacts, such as streaking and potential blooming, to avoid that such non-local artifacts are mistaken as pathological abnormalities.
In anisotropic materials or specific biological tissue
constituents, like lipid bilayers, proteins, muscle fibers or white matter
fiber bundles, susceptibility becomes orientation dependent with respect to an
external magnetic field and is then described by a symmetric second rank tensor.
To determine the six independent tensor elements requires multiple measurements
of frequency offsets at different orientations with respect to the field. With
a set of data given one can extract the full tensor, an approach that has been
exploited in STI to map white matter fiber orientation as well as to explore
fibrous and tubular tissues in the body.
Challenges that have to be met concern
subject movement and physiological motion that may introduce phase shifts that cannot
be explained within the field-to-susceptibility model ultimately leading to inaccurate
susceptibility maps and incorporation of orientation dependent microstructural effects into field-to-susceptibility models.
Mapping susceptibility provides a novel,
quantitative contrast of an intrinsic physical tissue quantity that reflects
the response of tissue to the presence of a static magnetic field. QSM and STI
represent important steps towards more specific imaging of tissue properties
and a major addition to the imaging armamentarium with important implications
for basic science and clinical applications.
Acknowledgements
No acknowledgement found.References
Haacke EM, Liu S, Buch S, Zheng W, Wu D, Ye Y. Quantitative susceptibility mapping: current status and future directions. Magn Reson Imaging 2015;33(1):1-25.
Liu C, Li W, Tong KA, Yeom KW, Kuzminski S. Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain. J Magn Reson Imaging 2015;42(1):23-41.
Liu C, Wei H, Gong NJ, Cronin M, Dibb R, Decker K. Quantitative susceptibility mapping: Contrast mechanisms and clinical applications. Tomography 2015;1(1):3-17
Reichenbach JR. The future of susceptibility contrast for assessment of anatomy and function. Neuroimage 2012;62(2):1311-5
Reichenbach JR, Schweser F, Serres B, Deistung A. Quantitative Susceptibility Mapping: Concepts and applications. Clin Neuroradiol 2015;25 Suppl 2:225-30.
Schweser F, Deistung A, Reichenbach JR. Foundations of MRI phase imaging and processing for Quantitative Susceptibility Mapping (QSM). Z Med Phys 2016;26(1):6-34
Wang Y, Liu T. Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker. Magn Reson Med 2015;73(1):82-101.